3-Oxo-2,3-dihydropyridazine-4-carboxylic acid, 95.0%, 500mg

3,5-Bis(trifluoromethyl)benzenesulfonyl chloride, 97.0%, 5g

N-(2-Chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine, 95.0%, 25g

4-Methyl-1,2,5-oxadiazol-3-amine, 95.0%, 2.5g

Lithium nitrate, min. 99.5%, anhydrous, 10 g, plastic packaging.

Mizoribine, 95%, 50mg

2,2,6-Trimethyl-1,3-dioxin-4-one>95.0%(NMR)500mL

6-Methylpyrimidine-4-carboxylic acid, 95.0%, 1g

(3aR,3'aR,8aS,8'aS)-2,2'-Cyclohexylidenebis[3a,8a-dihydro-dihydro-8H-indeno[1,2-d]oxazole, 97%, 250mg

Niobium(V) Oxide25g

N-Methylbut-3-en-1-amine hydrochloride, 97%, 5g

5,7-DIFLUOROQUINOLINE-6-CARBOXYLIC ACID, 95.0%, 50mg

Sodium 2-fluorobenzoate, 99.0%, 1g